- About UNAIDS
- Our work
- Targets and commitments
- 2011 Political Declaration: Targets and elimination commitments
- Reducing sexual transmission
- Preventing HIV among drug users
- Eliminating new HIV infections among children
- 15 million accessing treatment
- Avoiding TB deaths
- Closing the resource gap
- Eliminating gender inequalities
- Eliminating stigma and discrimination
- Eliminating travel restrictions
- Strengthening HIV integration
- 2011 Political Declaration: Targets and elimination commitments
More Office of the Chief Scientific Adviser to UNAIDS feature stories
- Continued investment in HIV prevention research can speed development of new options to help end the AIDS epidemic
- New global report released at IAS 2013 highlights funding trends, opportunities and challenges for HIV prevention R&D
- UNAIDS to establish international scientific expert panel on HIV
- UNAIDS’ new panel will convene a series of scientific consultations to ensure that the best scientific evidence is used to inform the global response to HIV
- Former UNAIDS Executive Director Dr Peter Piot wins prestigious Africa Health Prize
- The Japanese Government announced on 13 March that it was awarding the Second Hideyo Noguchi Africa prize to Dr Peter Piot, Director of the London School of Hygiene and Tropical Medicine in London, U.K. and former UNAIDS Executive Director and Dr Alex Godwin Coutinho, Executive Director of the Infectious Disease Institute, Makerere University in Kampala, Uganda.
- Continued investment into research and development for HIV treatment critical
- In a new UNAIDS funded report the Treatment Action Group (TAG) and AVAC have compiled information on investments into research and development for HIV treatment. The report was put together in a bid to analyse investment trends and highlight any gaps which may become apparent.
- Realising the potential impact of antiretroviral therapy
- The full results of a study on the effects of antiretroviral therapy in preventing new HIV infections have been published this week in the medical journal Science. The study, led by Professor Frank Tanser from the Africa Centre, spanned a seven year period (2004-2011), and followed nearly 17 000 people, the largest ever study of its kind to be completed.
- New UNAIDS platform highlights scientific advances
- In 2012 alone there were more than 14 000 scientific papers published on HIV. With such an impressive amount of information, it can be challenging to keep abreast of all the new developments. UNAIDS has launched an online platform, UNAIDS Science now, which highlights some of those papers that are particularly relevant to the United Nations high level targets.
- UNAIDS to collaborate with HSRC in HIV prevention research and policy development
- UNAIDS and the Human Sciences Research Council (HSRC) have signed a memorandum of understanding to strengthen research, policies, and programmes on HIV prevention globally, with a special emphasis on Africa.
- Finding an AIDS Vaccine in the Context of Combination Prevention
- From 9-12 September, more than a thousand HIV researchers and advocates, meeting in Boston for the AIDS Vaccine 2012 Conference, discussed the contribution of vaccine science to achieving the goal of zero new HIV infections in an increasingly complex HIV prevention landscape.
- A decade of progress and sustained funding for HIV prevention research provides a pathway for ending AIDS
- A decade of unprecedented investment in HIV prevention research has led to major scientific breakthroughs in vaccines, microbicides, voluntary medical male circumcision, treatment as prevention and pre-exposure prophylaxis, or PrEP, but sustained financing will be needed to capitalize on these breakthroughs to deliver new options that can help end the AIDS pandemic, according to a new report released today at the XIX International AIDS Conference in Washington, DC.
- Inaugural Global Scientific Strategy Towards an HIV Cure launched ahead of the XIX International AIDS Conference in Washington DC
- World´s leading HIV/AIDS Scientists and Stakeholders to gather in Washington D.C. to discuss Global Alliance on HIV Cure research
- The quest for an HIV vaccine
- There is broad scientific consensus that getting to zero new HIV infections will require an HIV vaccine. Modelling shows that even a partially effective HIV vaccine can save many lives and dollars over time.
- Women need access to dual protection—effective contraceptives and HIV prevention options
- A stakeholder consultation convened by the World Health Organization (WHO) in Geneva has reviewed recent epidemiological studies related to HIV transmission and acquisition by women using hormonal contraceptives. After careful review of all available evidence, the stakeholders found that the data were not sufficiently conclusive to change current guidance.
- Time for action, say HIV science roundtable participants
- The roundtable was entitled Closing the gap between science and implementation: Accelerating science to get to South Africa’s vision of zero new HIV infections, and looked at ways of maximizing the opportunities created by scientific research around HIV prevention in the past year to reach the country’s target of halving new HIV infections by 2015.
- Where innovation meets implementation
- In 2010 an announcement was made by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) which rocked the AIDS world and promised hope for millions of women around the world.
- New data from study roll-out provides further evidence that male circumcision is effective in preventing HIV in men
- The Joint United Nations Programme on HIV/AIDS (UNAIDS) strongly welcomes new results confirming that scaling-up adult male circumcision works to prevent HIV in men. The study, which was carried out in the township of Orange Farm in South Africa, resulted in a 55% reduction in HIV prevalence and a 76% reduction in HIV incidence in circumcised men.
- The Medicines Patent Pool announces negotiations with two additional pharmaceutical companies for patents on HIV medicines
- The Medicines Patent Pool announced that it has begun negotiations with Boehringer-Ingelheim and Bristol-Myers Squibb for patents on HIV medicines essential to treating people living with HIV in the developing world.
- 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention opens in Rome
- The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opened in Rome on 17 July. More than 5 000 AIDS researchers, scientists, clinicians, community leaders and policy experts have gathered to examine the latest developments in HIV-related research and to explore how scientific advances can inform the global response to AIDS.
- UNAIDS and WHO hail new results showing that a once-daily pill for HIV-negative people can prevent them from acquiring HIV
- New data from studies in Kenya, Uganda and Botswana confirm major role of antiretroviral medicine in preventing heterosexual HIV transmission
- Groundbreaking trial results confirm HIV treatment prevents transmission of HIV
- WHO and UNAIDS hail results from the HPTN 052 trial that show antiretroviral therapy to be 96% effective in reducing HIV transmission in couples where one partner has HIV
- amfAR briefing highlights roadmap to accelerating an HIV prevention revolution
- As part of amfAR’s emerging issues series, a briefing was held on Capitol Hill, in Washington, D.C. on 9 March entitled "Accelerating an HIV Prevention Revolution: A Roadmap". Speaking at the briefing, UNAIDS Deputy Executive Director Paul De Lay stressed the need to scale up combination HIV prevention worldwide.